Skip to main content

Advertisement

SpringerLink
Log in

Genetic disorders with immune dysregulation

  • Multi-author review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

We summarize the clinical presentation and molecular basis of a unique group of congenital immunodeficiency disorders in which defects in immune tolerance mechanisms result in severe autoimmunity. Patients with severe, familial forms of multi-organ autoimmunity have been recognized and clinically described for more than 40 years (Clin Exp Immunol 1: 119–128, 1966; Clin Exp Immunol 2: 19–30, 1967). Some are characterized primarily by autoimmunity and others by autoimmunity combined with susceptibility to specific infectious organisms. The first mechanistic understanding of these disorders began to emerge approximately 10 years ago with the initial identification of causative genes. As a result, our understanding of how immune tolerance is established and maintained in humans has expanded dramatically. Data generated over the last 3–4 years including identification of additional gene defects and functional characterization of each identified gene product in human and animal models have added clarity. This, in turn, has improved our ability to diagnose and effectively treat these severe, life-threatening disorders. Inherited disorders characterized by immune dysregulation have dramatically expanded our understanding of immune tolerance mechanisms in humans. Recognition and diagnosis of these disorders in the clinic allows timely initiation of life-saving therapies that may prevent death or irreversible damage to vital organs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Blizzard RM, Chee D, Davis W (1966) The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol 1:119–128

    PubMed  CAS  Google Scholar 

  2. Blizzard RM, Chee D, Davis W (1967) The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison’s disease). Clin Exp Immunol 2:19–30

    PubMed  CAS  Google Scholar 

  3. Anderson G, Lane PJ, Jenkinson EJ (2007) Generating intrathymic microenvironments to establish T-cell tolerance. Nat Rev Immunol 7:954–963

    Article  PubMed  CAS  Google Scholar 

  4. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836

    Article  PubMed  CAS  Google Scholar 

  5. Husebye ES, Perheentupa J, Rautemaa R, Kampe O (2009) Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 265:514–529

    Article  PubMed  CAS  Google Scholar 

  6. Alimohammadi M, Bjorklund P, Hallgren A, Pontynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerstrom G, Westin G, Scott HS, Hollander GA, Kampe O (2008) Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358:1018–1028

    Article  PubMed  CAS  Google Scholar 

  7. Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364

    Article  PubMed  CAS  Google Scholar 

  8. Soderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kampe O, Nilsson T (2004) Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 89:557–562

    Article  PubMed  Google Scholar 

  9. Alimohammadi M, Dubois N, Skoldberg F, Hallgren A, Tardivel I, Hedstrand H, Haavik J, Husebye ES, Gustafsson J, Rorsman F, Meloni A, Janson C, Vialettes B, Kajosaari M, Egner W, Sargur R, Ponten F, Amoura Z, Grimfeld A, De Luca F, Betterle C, Perheentupa J, Kampe O, Carel JC (2009) Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci USA 106:4396–4401

    Article  PubMed  CAS  Google Scholar 

  10. Shum AK, DeVoss J, Tan CL, Hou Y, Johannes K, O’Gorman CS, Jones KD, Sochett EB, Fong L, Anderson MS (2009) Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance. Sci Transl Med 1:9ra20

    Article  PubMed  Google Scholar 

  11. Levin M (2006) Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3:e292

    Article  PubMed  Google Scholar 

  12. Meager A, Visvalingam K, Peterson P, Moll K, Murumagi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N (2006) Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3:e289

    Article  PubMed  Google Scholar 

  13. Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachee-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougneres PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova JL (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207:291–297

    Article  PubMed  CAS  Google Scholar 

  14. Gavanescu I, Benoist C, Mathis D (2008) B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients. Proc Natl Acad Sci USA 105:13009–13014

    Article  PubMed  CAS  Google Scholar 

  15. Abramson J, Giraud M, Benoist C, Mathis D (2010) Aire’s partners in the molecular control of immunological tolerance. Cell 140:123–135

    Article  PubMed  CAS  Google Scholar 

  16. Fierabracci A (2011) Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity. Autoimmun Rev 10:137–143

    Article  PubMed  CAS  Google Scholar 

  17. Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A, Marcocci C (2001) A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 86:4747–4752

    Article  PubMed  CAS  Google Scholar 

  18. Perheentupa J (2006) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91:2843–2850

    Article  PubMed  CAS  Google Scholar 

  19. Proust-Lemoine E, Saugier-Veber P, Lefranc D, Dubucquoi S, Ryndak A, Buob D, Lalau JD, Desailloud R, Weill J, Prin L, Lefebvre H, Wemeau JL (2010) Autoimmune polyendocrine syndrome type 1 in north-western France: AIRE gene mutation specificities and severe forms needing immunosuppressive therapies. Horm Res Paediatr 74:275–284

    Article  PubMed  CAS  Google Scholar 

  20. Huter EN, Natarajan K, Torgerson TR, Glass DD, Shevach EM (2010) Autoantibodies in Scurfy mice and IPEX patients recognize keratin 14. J Invest Dermatol 130:1391–1399

    Article  PubMed  CAS  Google Scholar 

  21. McGinness JL, Bivens MM, Greer KE, Patterson JW, Saulsbury FT (2006) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 55:143–148

    Article  PubMed  Google Scholar 

  22. Tsuda M, Torgerson TR, Selmi C, Gambineri E, Carneiro-Sampaio M, Mannurita SC, Leung PS, Norman GL, Gershwin ME (2010) The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 35:265–268

    Article  PubMed  CAS  Google Scholar 

  23. Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW (2007) CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119:482–487

    Article  PubMed  CAS  Google Scholar 

  24. Sharfe N, Dadi HK, Shahar M, Roifman CM (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94:3168–3171

    Article  PubMed  CAS  Google Scholar 

  25. Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME (2006) IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27:50–53

    Article  PubMed  CAS  Google Scholar 

  26. Roifman CM (2000) Human IL-2 receptor alpha chain deficiency. Pediatr Res 48:6–11

    Article  PubMed  CAS  Google Scholar 

  27. D’Cruz LM, Klein L (2005) Development and function of agonist-induced CD25+ Foxp3+ regulatory T cells in the absence of interleukin-2 signaling. Nat Immunol 6:1152–1159

    Article  PubMed  Google Scholar 

  28. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY (2005) A function for interleukin-2 in Foxp3-expressing regulatory T cells. Nat Immunol 6:1142–1151

    Article  PubMed  CAS  Google Scholar 

  29. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG (2003) Growth hormone insenstivity associated with a STAT5b mutation. N Engl J Med 349:1139–1147

    Article  PubMed  CAS  Google Scholar 

  30. Nadeau K, Hwa V, Rosenfeld RG (2011) STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr (in press)

  31. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schaffer AA, Puck JM, Grimbacher B (2007) STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357:1608–1619

    Article  PubMed  CAS  Google Scholar 

  32. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448:1058–1062

    Article  PubMed  CAS  Google Scholar 

  33. Hwa V, Nadeau K, Wit JM, Rosenfeld RG (2011) STAT5b deficiency: lessons from STAT5b gene mutations. Best Pract Res Clin Endocrinol Metab 25:61–75

    Article  PubMed  CAS  Google Scholar 

  34. Lohr NJ, Molleston JP, Strauss KA, Torres-Martinez W, Sherman EA, Squires RH, Rider NL, Chikwava KR, Cummings OW, Morton DH, Puffenberger EG (2010) Human itch E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am J Hum Genet 86:447–453

    Article  PubMed  CAS  Google Scholar 

  35. Melino G, Gallagher E, Aqeilan RI, Knight R, Peschiaroli A, Rossi M, Scialpi F, Malatesta M, Zocchi L, Browne G, Ciechanover A, Bernassola F (2008) Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death Differ 15:1103–1112

    Article  PubMed  CAS  Google Scholar 

  36. Qiu L, Joazeiro C, Fang N, Wang HY, Elly C, Altman Y, Fang D, Hunter T, Liu YC (2000) Recognition and ubiquitination of notch by itch, a hect-type E3 ubiquitin ligase. J Biol Chem 275:35734–35737

    Article  PubMed  CAS  Google Scholar 

  37. Matesic LE, Copeland NG, Jenkins NA (2008) Itchy mice: the identification of a new pathway for the development of autoimmunity. Curr Top Microbiol Immunol 321:185–200

    Article  PubMed  CAS  Google Scholar 

  38. Perry WL, Hustad CM, Swing DA, O’Sullivan TN, Jenkins NA, Copeland NG (1998) The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat Genet 18:143–146

    Article  PubMed  CAS  Google Scholar 

  39. Venuprasad K (2010) Cbl-b and itch: key regulators of peripheral T-cell tolerance. Cancer Res 70:3009–3012

    Article  PubMed  CAS  Google Scholar 

  40. Venuprasad K, Huang H, Harada Y, Elly C, Subramaniam M, Spelsberg T, Su J, Liu YC (2008) The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat Immunol 9:245–253

    Article  PubMed  CAS  Google Scholar 

  41. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hatscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C (2009) Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361:2033–2045

    Article  PubMed  CAS  Google Scholar 

  42. Glocker EO, Frede N, Perro M, Sebire N, Elawad M, Shah N, Grimbacher B (2010) Infant colitis—it’s in the genes. Lancet 376:1272

    Article  PubMed  Google Scholar 

  43. Donnelly RP, Dickensheets H, Finbloom DS (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19:563–573

    Article  PubMed  CAS  Google Scholar 

  44. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822

    PubMed  CAS  Google Scholar 

  45. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274

    Article  PubMed  CAS  Google Scholar 

  46. Williams L, Bradley L, Smith A, Foxwell B (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172:567–576

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Sciences for Woman and Child’s Health, “Anna Meyer” Children’s Hospital, University of Florence, Florence, Italy

    Eleonora Gambineri

  2. Department of Pediatrics, University of Washington, Seattle, WA, USA

    Troy R. Torgerson

  3. Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle Children’s Hospital, 1900 9th Ave., C9S-7, Seattle, WA, 98101-1304, USA

    Troy R. Torgerson

Authors
  1. Eleonora Gambineri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Troy R. Torgerson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Troy R. Torgerson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gambineri, E., Torgerson, T.R. Genetic disorders with immune dysregulation. Cell. Mol. Life Sci. 69, 49–58 (2012). https://doi.org/10.1007/s00018-011-0838-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-011-0838-8

Keywords

Search

Navigation